Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05291676
PHASE2
Systems Investigation of Vaccine Responses in Aging and Frailty
Sponsor: Yale University
View on ClinicalTrials.gov
Summary
This study will compare the immune response signatures (including immunologic, transcriptomic and metabolomic) of the two influenza vaccines approved for use in adults age 65 and over (Fluad and Fluzone High-Dose).
Key Details
Gender
All
Age Range
21 Years - Any
Study Type
INTERVENTIONAL
Enrollment
96
Start Date
2023-11-06
Completion Date
2027-04
Last Updated
2025-06-12
Healthy Volunteers
Yes
Conditions
Interventions
BIOLOGICAL
Fluzone
Fluzone High-Dose 0.7 ml intramuscular injection, standard as recommended by manufacturer
BIOLOGICAL
Fluad
Fluad Quadrivalent, MF59 adjuvanted 0.5 ml intramuscular injection, standard as recommended by manufacturer
Locations (1)
Yale School of Medicine
New Haven, Connecticut, United States